Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
FleishmanHillard Launches Global Executive Advisory to Help Brands Navigate an Uncertain Marketplace
11:00am, Thursday, 29'th May 2025
New strategic network delivers integrated counsel at the intersection of risk, reputation and growth - backed by sector expertise, genAI solutions and global scale. NEW YORK and ST.
Edison confident of positive outcome in Venture Global LNG arbitration
09:22am, Thursday, 29'th May 2025
The chief executive of Italian utility Edison said on Thursday he was confident of a positive outcome in arbitration involving U.S. liquefied natural gas supplier Venture Global , expected by the end
Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System
09:15am, Thursday, 29'th May 2025
Following successful clinical implementations in the U.S., Inspira accelerates commercialization of its system. The Company is already engaged in discussions with governmental health departments and p
P&G to Webcast Presentation From the Deutsche Bank dbAccess Global Consumer Conference, June 5, 2025
09:15am, Thursday, 29'th May 2025
CINCINNATI--(BUSINESS WIRE)--Shailesh Jejurikar, Chief Operating Officer and Andre Schulten, Chief Financial Officer of The Procter & Gamble Company (NYSE:PG) will be featured speakers at the Deutsche
Interactive Brokers Group to Present at Piper Sandler Global Exchange & Trading Conference
09:00am, Thursday, 29'th May 2025
GREENWICH, Conn.--(BUSINESS WIRE)---- $IBKR #IBKR--Interactive Brokers Group, Inc. (Nasdaq: IBKR) announces that its Chairman Thomas Peterffy will speak at the Piper Sandler Global Exchange & Trading
Data I/O Announces Significant Automated Programming System Order From Leading Global Automotive EV Supplier
08:30am, Thursday, 29'th May 2025
Redmond, Washington--(Newsfile Corp. - May 29, 2025) - Data I/O Corporation (NASDAQ: DAIO), the leading global provider of advanced security and data deployment solutions for microcontrollers, securit
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
08:30am, Thursday, 29'th May 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
08:30am, Thursday, 29'th May 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.
Beyond Oil Announces Exclusive Distribution Agreement in Mexico with Baruchi Global Capital
08:30am, Thursday, 29'th May 2025
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, May 29, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company de
Robinhood Markets, Inc. to Present at the Piper Sandler Global Exchange & Trading Conference on June 5, 2025
08:30am, Thursday, 29'th May 2025
MENLO PARK, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Piper Sandler Global Exchang
Septerna to Present at Jefferies Global Healthcare Conference
08:00am, Thursday, 29'th May 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today ann
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
08:00am, Thursday, 29'th May 2025
DUBLIN, Ireland, May 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that memb
Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
08:00am, Thursday, 29'th May 2025
THE WOODLANDS, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2025 Jefferies Gl
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
08:00am, Thursday, 29'th May 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic m
Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference
08:00am, Thursday, 29'th May 2025
WATERTOWN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development
